.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Cipla
Fish and Richardson
Chubb
Covington
Johnson and Johnson
US Department of Justice
Express Scripts
Harvard Business School

Generated: June 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080618

« Back to Dashboard
NDA 080618 describes PYRIDOXINE HYDROCHLORIDE, which is a drug marketed by Fresenius Kabi Usa, Watson Labs, Bel Mar, Akorn, Luitpold, Dell Labs, Mylan Institutional, and Elkins Sinn, and is included in ten NDAs. It is available from two suppliers. Additional details are available on the PYRIDOXINE HYDROCHLORIDE profile page.

The generic ingredient in PYRIDOXINE HYDROCHLORIDE is pyridoxine hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pyridoxine hydrochloride profile page.

Summary for NDA: 080618

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 080618

Suppliers and Packaging for NDA: 080618

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PYRIDOXINE HYDROCHLORIDE
pyridoxine hydrochloride
INJECTABLE;INJECTION 080618 ANDA Fresenius Kabi USA, LLC 63323-180 63323-180-01 25 VIAL in 1 TRAY (63323-180-01) > 1 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength100MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Baxter
Queensland Health
Merck
Julphar
Citi
Accenture
Moodys
Novartis
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot